Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)

Clinical and Experimental Immunology

Volumn 119, Issue 3, 2000, Pages 419-425

  Klemetti, P ^a,b   Bjorses P ^a   Tuomi, T ^c   Perheentupa, J ^b   Partanen, J ^d   Rautonen, N ^e   Hinkkanen, A ^f   Ilonen, J ^f   Vaarala, Outi ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Finnish Red Cross   (Finland)

^e Danisco Cultor   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

GAD antibodies; HLA cytokines; Insulin dependent diabetes; T lymphocytes

Indexed keywords

GAMMA INTERFERON; GLUCOSE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CLINICAL ARTICLE; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LYMPHOCYTE PROLIFERATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SCHOOL CHILD; SYNDROME DELINEATION;

EID: 0034019966     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01167.x     Document Type: Article

References (23)

1. 1 Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322:1829-36.
2. 2 Whitaker J, Landing BH, Esselbom VM, Williams RR. The syndrome of familial juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis. J Clin Endocrin Metab 1956; 16:1374-87.
3. 3 Neufeldt M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann 1980; 9:154-62.
4. 4 The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Genet 1997; 17:399-403.
5. 5 Nagamine K, Peterson P, Scott HS et al. Positional cloning of the APECED gene. Nature Genet 1997; 17:393-8.
6. 6 Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark Å, Miettinen A. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune disease type I. J Clin Endocrin Metab 1996; 81:1488-94.
7. 7 Baekkeskov S, Aanstoot H-J, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:151-6.
8. 8 Atkinson MA, Kaufman DL, Campbell L et al. Response of peripheral blood mononuclear cells to glutamate decarboxylase in insulin-dependent mellitus. Lancet 1992; 339:458-9.
9. 9 Honeyman M, Cram D, Harrison L. Glutamic acid decarboxylase 67-reactive cells: a marker of insulin-dependent diabetes. J Exp Med 1993; 177:535-740.
10. 10 Harrison LC, Honeyman MC, DeAizpura HJ, Schmidli RS, Colman PG, Tait BD, Scram DS. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341:1365-9.
11. 11 Worsaae A, Hejnaes K, Moody A, Ludvigsson J, Pociot F, Lorenzen T, Dyrberg T. T cell proliferation responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity 1995; 22:183-9.
12. 12 Moody AJ, Hejnaes KR, Marshall MO, Larsen FS, Boel E, Svendsen I, Mortensen E, Dyrberg T. Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in Sf9 insect cells. Diabetologia 1995; 38:14-23.
13. 13 Paronen J, Klemetti P, Kantele JM, Savilahti E, Perheentupa J, Åkerblom HK, Vaarala O. Glutamate decarboxylase reactive peripheral blood lymphocytes from patients with insulin-dependent diabetes mellitus express gut-specific homing receptor α4β7-integrin. Diabetes 1997; 46:583-8.
14. 14 Halminen M, Klemetti P, Vaarala O, Hurme M, Ilonen J. Interferon-γ production in antigen specific T cell response: quantitation of specific mRNA and secreted protein. Scand J Immunol 1997; 46:388-92.
15. 15 Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Sasazuki T, ed. HLA, Vol 1. Oxford: Oxford University Press, 1991:397-42.
16. 16 Grubin CE, Daniels T, Toivola B et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37:344-50.
17. 3H recombinant human ligands. J Immunol Methods 1995; 186:89-99.
18. 18 Del Prete GF, De Carli M, Ricci M, Romagnani S. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity. J Exp Med 1991; 174:809-913.
19. 19 Evavold BD, Sloan-Lancaster J, Allen PM. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today 1993; 14:602-9.
20. 20 Hagopian WA, Sanjeevi CB, Kockum I et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995; 95:1505-11.
21. 21 Genovese S, Bonfanti R, Bazzigaluppi E, Lampasona V, Benazzi E, Bosi E, Chiumello G, Bonifacio E. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 1996; 39:1223-6.
22. 22 Björk E, Velloso LA, Kämpe O, Karlsson A. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994; 43:161-5.
23. 23 Wagner R, McNally J, Bonifacio E et al. Lack of immunohistochemical changes in the islets of nondiabetic, autoimmune, polyendocrine patients with β-selective GAD-specific islet antibodies. Diabetes 1994; 43:851-6.